RecruitingNCT03732131

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study


Sponsor

Joint Authority for Päijät-Häme Social and Health Care

Enrollment

200 participants

Start Date

Oct 18, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Inclusion Criteria4

  • > 18 years age
  • receiving FMT for rCDI or any other madical condition
  • written consent
  • Not included in other FMT trials

Exclusion Criteria3

  • Unable to provide written consent
  • < 18 years age
  • Included in other FMT-trial

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Joint Authority for Päijät-Häme Social and Health Care

Lahti, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03732131


Related Trials